GNG11

gene
On this page

Also known as GNGT11

Summary

GNG11 (G protein subunit gamma 11, HGNC:4403) is a protein-coding gene on chromosome 7q21.3, encoding Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 (P61952). Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems.

This gene is a member of the guanine nucleotide-binding protein (G protein) gamma family and encodes a lipid-anchored, cell membrane protein. As a member of the heterotrimeric G protein complex, this protein plays a role in this transmembrane signaling system. This protein is also subject to carboxyl-terminal processing. Decreased expression of this gene is associated with splenic marginal zone lymphomas.

Source: NCBI Gene 2791 — RefSeq curated summary.

At a glance

  • GWAS associations: 14
  • Clinical variants (ClinVar): 4 total — 1 pathogenic
  • MANE Select transcript: NM_004126

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:4403
Approved symbolGNG11
NameG protein subunit gamma 11
Location7q21.3
Locus typegene with protein product
StatusApproved
AliasesGNGT11
Ensembl geneENSG00000127920
Ensembl biotypeprotein_coding
OMIM604390
Entrez2791

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000248564

RefSeq mRNA: 1 — MANE Select: NM_004126 NM_004126

CCDS: CCDS5634

Canonical transcript exons

ENST00000248564 — 2 exons

ExonStartEnd
ENSE000008773349392609193928610
ENSE000010316729392173593922233

Expression profiles

Bgee: expression breadth ubiquitous, 282 present calls, max score 98.48.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 110.2123 / max 1543.2620, expressed in 1401 samples.

FANTOM5 promoters (9 alternative TSS)

Promoter IDTPM avgSamples expressed
7958335.70401293
7957727.14411217
7957615.33571137
7957811.81121090
7958410.07661089
795826.84921037
795791.1999523
795801.1543551
795810.9373453

Top tissues by expression

294 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
pigmented layer of retinaUBERON:000178298.48gold quality
tendon of biceps brachiiUBERON:000818898.27gold quality
periodontal ligamentUBERON:000826698.03gold quality
monocyteCL:000057697.42gold quality
stromal cell of endometriumCL:000225597.37gold quality
mammary ductUBERON:000176597.34gold quality
mononuclear cellCL:000084297.13gold quality
germinal epithelium of ovaryUBERON:000130496.96gold quality
seminal vesicleUBERON:000099896.81gold quality
parietal pleuraUBERON:000240096.50gold quality
placentaUBERON:000198796.32gold quality
adipose tissueUBERON:000101396.07gold quality
leukocyteCL:000073896.05gold quality
diaphragmUBERON:000110396.00gold quality
adult organismUBERON:000702395.99gold quality
metanephric glomerulusUBERON:000473695.93gold quality
connective tissueUBERON:000238495.82gold quality
adipose tissue of abdominal regionUBERON:000780895.76gold quality
heart right ventricleUBERON:000208095.69gold quality
renal glomerulusUBERON:000007495.60gold quality
omental fat padUBERON:001041495.55gold quality
peritoneumUBERON:000235895.53gold quality
pleuraUBERON:000097795.48gold quality
synovial jointUBERON:000221795.12gold quality
skin of hipUBERON:000155495.07gold quality
subcutaneous adipose tissueUBERON:000219094.86gold quality
vena cavaUBERON:000408794.80gold quality
deciduaUBERON:000245094.63gold quality
lower lobe of lungUBERON:000894994.39gold quality
epithelium of mammary glandUBERON:000324494.28gold quality

Single-cell (SCXA)

Detected in 65 experiment(s), a significant marker in 62.

ExperimentMarker?Max mean expression
E-MTAB-10432yes11594.28
E-GEOD-139324yes9796.07
E-MTAB-8207yes8458.84
E-MTAB-6701yes8287.31
E-MTAB-9221yes6652.80
E-GEOD-149689yes6410.44
E-HCAD-4yes5715.29
E-MTAB-6308yes4131.89
E-HCAD-24yes4005.98
E-GEOD-124263yes3846.62
E-GEOD-130148yes3806.10
E-MTAB-10662yes3658.42
E-MTAB-7407yes3504.24
E-HCAD-1yes3491.73
E-HCAD-11yes2742.06

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

26 targeting GNG11, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3667-3P99.9967.171636
HSA-MIR-493-5P99.9672.472382
HSA-MIR-495-3P99.9672.814197
HSA-MIR-568899.9673.234504
HSA-MIR-652-5P99.9167.49505
HSA-MIR-5582-3P99.8672.484221
HSA-MIR-132399.8369.892471
HSA-MIR-6875-3P99.8270.262983
HSA-MIR-4668-5P99.7970.583782
HSA-MIR-4766-5P99.7569.232662
HSA-MIR-548O-3P99.7469.302228
HSA-MIR-442299.7272.072908
HSA-MIR-4677-5P99.7070.091940
HSA-MIR-58799.6470.862611
HSA-MIR-2116-5P99.3269.341273
HSA-MIR-10524-5P99.0566.08963
HSA-MIR-6728-3P98.6367.631534
HSA-MIR-4720-3P98.5068.88988
HSA-MIR-204-3P97.8066.841656
HSA-MIR-4646-5P97.7066.841692
HSA-MIR-22-5P97.6768.921355
HSA-MIR-431497.5067.301369
HSA-MIR-4436B-5P96.7168.371346
HSA-MIR-454-5P96.5168.35263
HSA-MIR-317494.6363.64577
HSA-MIR-1298-3P94.0564.84620

Literature-anchored findings (GeneRIF, showing 2)

  • Collectively, these results suggest a novel senescence pathway mediated by GNG11 in response to environmental cues. (PMID:17092487)
  • expression of GNG11 induced the generation of reactive oxygen species (ROS) and abnormal nuclear morphology in SUSM-1 cells but not in HeLa cells (PMID:28380310)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriogngt1ENSDARG00000035798
mus_musculusGng11ENSMUSG00000032766
rattus_norvegicusGng11ENSRNOG00000050469
drosophila_melanogasterGgamma1FBGN0004921

Paralogs (11): GNGT1 (ENSG00000127928), GNG5B (ENSG00000133136), GNG3 (ENSG00000162188), GNGT2 (ENSG00000167083), GNG8 (ENSG00000167414), GNG4 (ENSG00000168243), GNG12 (ENSG00000172380), GNG5 (ENSG00000174021), GNG7 (ENSG00000176533), GNG2 (ENSG00000186469), GNG10 (ENSG00000242616)

Protein

Protein identifiers

Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11P61952 (reviewed: P61952)

All UniProt accessions (2): P61952, Q53Y01

UniProt curated annotations — full annotation on UniProt →

Function. Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.

Subunit / interactions. G proteins are composed of 3 units, alpha, beta and gamma. Interacts with beta-1 and beta-3, but not with beta-2.

Subcellular location. Cell membrane.

Tissue specificity. Abundantly expressed in all tissues tested except for brain.

Similarity. Belongs to the G protein gamma family.

RefSeq proteins (1): NP_004117* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001770G-protein_gammaFamily
IPR015898G-protein_gamma-like_domDomain
IPR036284GGL_sfHomologous_superfamily

Pfam: PF00631

UniProt features (5 total): chain 1, propeptide 1, region of interest 1, modified residue 1, lipid moiety-binding region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P61952-F188.610.59

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 70, 70

Function

Pathways and Gene Ontology

Reactome pathways

29 pathways

IDPathway
R-HSA-1296041Activation of G protein gated Potassium channels
R-HSA-163359Glucagon signaling in metabolic regulation
R-HSA-202040G-protein activation
R-HSA-381676Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
R-HSA-392170ADP signalling through P2Y purinoceptor 12
R-HSA-392451G beta:gamma signalling through PI3Kgamma
R-HSA-392851Prostacyclin signalling through prostacyclin receptor
R-HSA-400042Adrenaline,noradrenaline inhibits insulin secretion
R-HSA-4086398Ca2+ pathway
R-HSA-416476G alpha (q) signalling events
R-HSA-416482G alpha (12/13) signalling events
R-HSA-418217G beta:gamma signalling through PLC beta
R-HSA-418555G alpha (s) signalling events
R-HSA-418592ADP signalling through P2Y purinoceptor 1
R-HSA-418594G alpha (i) signalling events
R-HSA-418597G alpha (z) signalling events
R-HSA-420092Glucagon-type ligand receptors
R-HSA-428930Thromboxane signalling through TP receptor
R-HSA-432040Vasopressin regulates renal water homeostasis via Aquaporins
R-HSA-456926Thrombin signalling through proteinase activated receptors (PARs)
R-HSA-500657Presynaptic function of Kainate receptors
R-HSA-6814122Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
R-HSA-8964315G beta:gamma signalling through BTK
R-HSA-8964616G beta:gamma signalling through CDC42
R-HSA-9009391Extra-nuclear estrogen signaling
R-HSA-9634597GPER1 signaling
R-HSA-9660821ADORA2B mediated anti-inflammatory cytokines production
R-HSA-9856530High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
R-HSA-997272Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits

MSigDB gene sets: 312 (showing top): GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP, GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP, BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP, MODULE_52, WALLACE_PROSTATE_CANCER_RACE_UP, REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS, REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION, REACTOME_POTASSIUM_CHANNELS, REACTOME_INWARDLY_RECTIFYING_K_CHANNELS, REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION, REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS, MODULE_45, MODULE_64, REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION, LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN

GO Biological Process (2): signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186)

GO Molecular Function (3): GTPase activity (GO:0003924), G-protein beta-subunit binding (GO:0031681), protein binding (GO:0005515)

GO Cellular Component (3): heterotrimeric G-protein complex (GO:0005834), plasma membrane (GO:0005886), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-12 pathways:

CategoryPathways
GPCR downstream signalling5
Signal amplification3
Regulation of insulin secretion2
G-protein beta:gamma signalling2
G protein gated Potassium channels1
Integration of energy metabolism1
Opioid Signalling1
Platelet homeostasis1
Beta-catenin independent WNT signaling1
Class B/2 (Secretin family receptors)1
Aquaporin-mediated transport1
Platelet activation, signaling and aggregation1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cell communication1
cellular process1
signaling1
regulation of cellular process1
cellular response to stimulus1
G protein-coupled receptor activity1
signal transduction1
ribonucleoside triphosphate phosphatase activity1
protein binding1
binding1
extrinsic component of cytoplasmic side of plasma membrane1
plasma membrane protein complex1
GTPase complex1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

0 interactions, top by confidence (×1000):

IntAct

34 interactions, top by confidence:

ABTypeScore
GNAI3RGS12psi-mi:“MI:0914”(association)0.640
GNG11CEP44psi-mi:“MI:0915”(physical association)0.560
GNG11REP15psi-mi:“MI:0915”(physical association)0.560
GNG11GNB1psi-mi:“MI:0914”(association)0.500
GNG11GNB2psi-mi:“MI:0914”(association)0.500
GNG11GNB3psi-mi:“MI:0914”(association)0.500
GNB4GNG11psi-mi:“MI:0915”(physical association)0.500
GNB3GNG11psi-mi:“MI:0915”(physical association)0.500
GNB2GNG11psi-mi:“MI:0915”(physical association)0.500
GNB1GNG11psi-mi:“MI:0915”(physical association)0.500
GNG11PDCLpsi-mi:“MI:0915”(physical association)0.400
GNG11AMOTL2psi-mi:“MI:0915”(physical association)0.370
GNG11GNAI1psi-mi:“MI:0914”(association)0.350
GNG11GNASpsi-mi:“MI:0914”(association)0.350
GNG11Ntsr1psi-mi:“MI:0914”(association)0.350
GNASGNG11psi-mi:“MI:0914”(association)0.350
SMURF1GNG11psi-mi:“MI:2364”(proximity)0.270
GNG11CEP44psi-mi:“MI:0915”(physical association)0.000

BioGRID (19): GNG11 (Two-hybrid), MEOX2 (Two-hybrid), CEP44 (Two-hybrid), GNG11 (Affinity Capture-MS), AMOTL2 (Two-hybrid), GNG11 (Co-localization), GNG11 (Affinity Capture-MS), PDCL (Affinity Capture-MS), ZHX1 (Two-hybrid), CEP44 (Two-hybrid), REP15 (Two-hybrid), GNG11 (Reconstituted Complex), GNG11 (Reconstituted Complex), GNG11 (Affinity Capture-MS), GNG11 (Affinity Capture-MS)

ESM2 similar proteins: A0A804HLA8, O14610, O60262, O97564, P02698, P30671, P38040, P43425, P50150, P50151, P50153, P50154, P54406, P59768, P61952, P61953, P61954, P63077, P63078, P63210, P63211, P63212, P63213, P63214, P63215, P63216, P63217, P63218, P63219, Q28024, Q4VT26, Q5E9F0, Q5R639, Q5R7U4, Q5RBQ0, Q5REH7, Q61012, Q61016, Q61017, Q6CPB4

Diamond homologs: O14610, O60262, O97564, P02698, P30671, P43425, P50150, P50151, P50153, P50154, P54406, P59768, P61952, P61953, P61954, P63077, P63078, P63210, P63211, P63212, P63213, P63214, P63215, P63216, P63217, P63218, P63219, Q28024, Q5E9F0, Q5R639, Q5R7U4, Q5RBQ0, Q5REH7, Q61012, Q61016, Q61017, Q80SZ7, Q9CXP8, Q9DAS9, Q9NFZ2

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 15 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Prostacyclin signalling through prostacyclin receptor5273.2×4e-11
ADP signalling through P2Y purinoceptor 126270.8×2e-13
Adrenaline,noradrenaline inhibits insulin secretion5179.0×2e-10
ADORA2B mediated anti-inflammatory cytokines production7161.5×1e-13
GPER1 signaling7158.0×1e-13
Glucagon signaling in metabolic regulation5157.3×4e-10
Glucagon-type ligand receptors5157.3×4e-10
G alpha (z) signalling events7148.3×1e-13

GO biological processes:

GO termPartnersFoldFDR
G protein-coupled receptor signaling pathway718.1×4e-06

Disease & clinical

Clinical variants and AI predictions

ClinVar

4 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance1
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
563412GRCh37/hg19 7q21.3(chr7:93285237-96280817)x1Pathogenic

SpliceAI

108 predictions. Top by Δscore:

VariantEffectΔscore
7:93922230:ACAA:Adonor_gain1.0000
7:93922231:CAA:Cdonor_gain1.0000
7:93922233:AG:Adonor_loss1.0000
7:93922234:G:GGdonor_gain1.0000
7:93922229:AACAA:Adonor_gain0.9900
7:93922232:AA:Adonor_gain0.9900
7:93926083:T:Gacceptor_gain0.9900
7:93926084:A:AGacceptor_gain0.9900
7:93926089:A:AGacceptor_loss0.9900
7:93926089:A:Gacceptor_gain0.9900
7:93926090:G:GCacceptor_loss0.9900
7:93926090:GGT:Gacceptor_gain0.9800
7:93922210:G:GTdonor_gain0.9700
7:93926088:A:AGacceptor_gain0.9700
7:93926088:AAG:Aacceptor_gain0.9700
7:93922214:TG:Tdonor_gain0.9600
7:93926082:A:AGacceptor_gain0.9600
7:93926085:C:Gacceptor_gain0.9600
7:93922189:G:GTdonor_gain0.9500
7:93926090:G:GGacceptor_gain0.9400
7:93922215:G:GTdonor_gain0.9300
7:93922237:A:AGdonor_gain0.9000
7:93922238:G:GGdonor_gain0.9000
7:93926088:AAGGT:Aacceptor_gain0.9000
7:93926090:GGTGT:Gacceptor_gain0.8800
7:93926197:G:GTdonor_gain0.8500
7:93926198:C:Tdonor_gain0.8500
7:93926090:G:Aacceptor_gain0.8300
7:93926246:G:GTdonor_gain0.8100
7:93926089:AG:Aacceptor_gain0.7800

AlphaMissense

480 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:93922227:A:CR30S0.997
7:93922227:A:TR30S0.997
7:93922202:T:CL22P0.995
7:93922226:G:CR30T0.995
7:93926184:T:CF64L0.991
7:93926186:T:AF64L0.991
7:93926186:T:GF64L0.991
7:93926180:C:AN62K0.989
7:93926180:C:GN62K0.989
7:93922226:G:TR30I0.987
7:93926145:G:CD51H0.987
7:93926146:A:CD51A0.987
7:93926147:T:AD51E0.987
7:93926147:T:GD51E0.987
7:93926146:A:GD51G0.985
7:93926146:A:TD51V0.985
7:93926152:T:CL53P0.985
7:93926152:T:AL53Q0.984
7:93926185:T:CF64S0.984
7:93926184:T:AF64I0.983
7:93926189:A:CK65N0.982
7:93926189:A:TK65N0.982
7:93922199:A:CQ21P0.979
7:93926178:A:GN62D0.979
7:93922225:A:GR30G0.978
7:93926113:T:AI40K0.978
7:93926113:T:GI40R0.976
7:93926125:T:AI44N0.976
7:93926152:T:GL53R0.976
7:93926181:C:TP63S0.976

dbSNP variants (sampled 300 via entrez): RS1000016433 (7:93921801 G>T), RS1000139722 (7:93925826 TGACCAAC>T), RS1000536198 (7:93921333 C>T), RS1000861076 (7:93927307 C>T), RS1000975201 (7:93926984 C>T), RS1001048813 (7:93925023 G>A), RS1001432773 (7:93920552 G>A), RS1002386024 (7:93925056 T>TGGGAGGCTGA), RS1002476447 (7:93919845 T>A,C), RS1002539929 (7:93923370 A>G), RS1002550411 (7:93927932 A>G), RS1002768563 (7:93920109 A>T), RS1003947060 (7:93925468 T>C), RS1003997705 (7:93925225 A>G), RS1004866882 (7:93922167 A>G)

Disease associations

OMIM: gene MIM:604390 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

14 associations (top):

StudyTraitp-value
GCST001969_2Heart rate7.000000e-12
GCST003818_37Resting heart rate5.000000e-21
GCST004732_11Heart rate variability traits (pvRSA/HF)2.000000e-11
GCST004732_12Heart rate variability traits (pvRSA/HF)2.000000e-11
GCST004733_14Heart rate variability traits (RMSSD)8.000000e-16
GCST004733_15Heart rate variability traits (RMSSD)8.000000e-19
GCST004734_19Heart rate variability traits (SDNN)4.000000e-17
GCST004734_9Heart rate variability traits (SDNN)5.000000e-19
GCST004863_15Mosquito bite size2.000000e-07
GCST005846_6Heart rate response to recovery post exercise (10 sec)7.000000e-12
GCST005847_8Heart rate response to recovery post exercise (20 sec)9.000000e-11
GCST005848_14Heart rate response to recovery post exercise (50 sec)4.000000e-11
GCST005849_13Heart rate response to recovery post exercise (40 sec)2.000000e-12
GCST005850_5Heart rate response to recovery post exercise (30 sec)2.000000e-11

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0008003heart rate variability measurement
EFO:0008378mosquito bite reaction size measurement
EFO:0009185heart rate response to recovery post exercise

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

60 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Aciddecreases expression, increases methylation, affects cotreatment, increases expression, affects expression8
Benzo(a)pyreneincreases expression, increases methylation4
trichostatin Aaffects cotreatment, increases expression3
Air Pollutantsdecreases expression, increases abundance3
Aflatoxin B1affects expression, increases expression, increases methylation3
Particulate Matterdecreases expression, increases abundance3
bisphenol Adecreases expression, affects cotreatment2
cobaltous chloridedecreases expression2
Vorinostatincreases expression, affects cotreatment2
Panobinostataffects cotreatment, increases expression2
Acetaminophendecreases expression, increases expression2
Estradiolaffects expression, affects cotreatment, increases expression2
Phenylmercuric Acetateaffects cotreatment, increases expression2
Smokedecreases expression, increases expression2
Tetrachlorodibenzodioxinincreases expression2
Tretinoindecreases expression, increases expression2
Asbestos, Crocidoliteincreases expression2
aristolochic acid Idecreases expression1
2,4-dichlorophenolincreases methylation1
methylmercuric chlorideincreases expression1
triphenyl phosphateaffects expression1
lead acetateincreases expression1
2,5,2’,5’-tetrachlorobiphenylincreases expression1
arseniteaffects binding, increases reaction1
methylparabendecreases expression1
sodium arseniteincreases expression1
zinc chromateincreases abundance, increases expression1
bleomycetindecreases expression1
cupric chlorideincreases expression1
nickel sulfateincreases expression1

Cellosaurus cell lines

1 cell lines: 1 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_B1T3Abcam HeLa GNG11 KOCancer cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.